MedPath

Remetinostat

Generic Name
Remetinostat
Drug Type
Small Molecule
Chemical Formula
C16H21NO6
CAS Number
946150-57-8
Unique Ingredient Identifier
37NT056AT4

Overview

Remetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).

Background

Remetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)
Phase 2
Terminated
Posted: 2019/03/15
Sponsor:
Kavita Sarin
ID:NCT03875859
Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer
Phase 2
Completed
Posted: 2017/06/08
Sponsor:
Kavita Sarin
ID:NCT03180528
Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
Phase 2
Posted: 2015/12/21
Sponsor:
TetraLogic Pharmaceu...
ID:NCT02636244
Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma
Phase 2
Posted: 2014/08/12
Sponsor:
TetraLogic Pharmaceu...
ID:NCT02213861
SHP-141C in Plaque Type Psoriasis
Phase 1
Completed
Posted: 2012/07/20
Sponsor:
TetraLogic Pharmaceu...
ID:NCT01646567

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy